<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04551742</url>
  </required_header>
  <id_info>
    <org_study_id>19-29632</org_study_id>
    <nct_id>NCT04551742</nct_id>
  </id_info>
  <brief_title>Social &amp; Contextual Impact on Children Undergoing Liver Transplantation</brief_title>
  <acronym>SOCIAL-TX</acronym>
  <official_title>Social &amp; Contextual Impact on Children Undergoing Liver Transplantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, San Francisco</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The social determinants of health have a large impact on health. For example, neighborhood&#xD;
      socioeconomic deprivation is associated with increased risk of medication non-adherence,&#xD;
      graft failure, and death in children after liver transplant. In order to address these&#xD;
      socioeconomic inequities in outcomes, a more granular understanding of how the social&#xD;
      determinants of health impact outcomes is needed. In this observational prospective cohort,&#xD;
      caregivers of children undergoing liver transplantation will complete surveys and undergo&#xD;
      in-depth, qualitative interviews. The survey will assess comprehensively for the social&#xD;
      determinants of health (e.g. material economic hardship, health literacy, social&#xD;
      connectedness, primary care quality, etc). The qualitative interviews will identify barriers&#xD;
      and facilitators that socioeconomically deprived children/families have to obtaining the&#xD;
      ideal outcome and identify health system opportunities to integrate social needs and medical&#xD;
      care. Data will be linked to an existing prospective cohort study (The Society for Pediatric&#xD;
      Liver Transplant registry) to assess the impact of social risk on outcomes after transplant.&#xD;
&#xD;
      Healthcare providers who take care of children undergoing liver transplant will also be&#xD;
      included in the qualitative interviews. The goal of including this group in the study is to&#xD;
      determine the health systems barriers and facilitators to social needs screening and&#xD;
      intervention.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 16, 2020</start_date>
  <completion_date type="Anticipated">December 2024</completion_date>
  <primary_completion_date type="Anticipated">December 2024</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of days hospitalized within 90 days after transplant, including the initial transplant hospitalization</measure>
    <time_frame>90 Days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Episodes of acute cellular rejection</measure>
    <time_frame>1 Year</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Ideal Outcome-3 (IO-3)</measure>
    <time_frame>3 Years</time_frame>
    <description>The ideal outcome measure is a composite measure of morbidity after transplant defined as alive, ALT and GGT &lt;50, normal GFR, no non-liver transplants, no cytopenias, and no PTLD.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Readmission within 90 days after transplant</measure>
    <time_frame>90 Days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Episode of biopsy-proven acute cellular rejection within 90 days after transplant</measure>
    <time_frame>90 Days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Episode of re-transplantation</measure>
    <time_frame>3 Years</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Liver Transplantation</condition>
  <condition>Liver Diseases</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Caregivers or parents of children undergoing liver transplantation Healthcare professionals&#xD;
        caring for children undergoing liver transplantation&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Caregivers/parents of children with the following criteria will be approached for inclusion&#xD;
        in this study:&#xD;
&#xD;
          -  Children &lt;18 years of age at the time of transplant&#xD;
&#xD;
          -  Undergoing liver transplantation&#xD;
&#xD;
          -  Guardian's consent, child assent (in accordance with each institution's IRB policies)&#xD;
&#xD;
          -  Consents to enrollment in SPLIT&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Caregivers/parents of children undergoing liver transplantation will be excluded it:&#xD;
&#xD;
          -  Caregiver unwilling or unable to complete the survey&#xD;
&#xD;
          -  Child is a ward of the state (e.g., foster care) since present circumstances may not&#xD;
             be reflective of child's past or future circumstances&#xD;
&#xD;
          -  Non-English, non-Spanish speakers&#xD;
&#xD;
          -  Non-US residents&#xD;
&#xD;
          -  Declined participation in SPLIT&#xD;
&#xD;
        Inclusion Criteria for Interview Portion of the Study:&#xD;
&#xD;
          -  Participants who have completed the questionnaire OR&#xD;
&#xD;
          -  Medical team member involved in the care of children undergoing liver transplant&#xD;
             (e.g., physician, nurse, social worker)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sharad Wadhwani, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Francisco</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Emily Stekol</last_name>
    <phone>415-502-3190</phone>
    <email>emily.stekol@ucsf.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Children's Hospital Los Angeles</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90027</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carly Weaver</last_name>
      <phone>774-258-0286</phone>
      <email>cweaver@chla.usc.edu</email>
    </contact>
    <investigator>
      <last_name>Shannon Zielsdorf, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lucile Packard Children's Hospital</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94304</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Noelle Ebel, MD</last_name>
      <phone>650-721-2250</phone>
      <email>nebel@stanford.edu</email>
    </contact>
    <investigator>
      <last_name>Noelle Ebel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94158</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emily Stekol</last_name>
      <phone>415-502-3190</phone>
      <email>emily.stekol@ucsf.edu</email>
    </contact>
    <investigator>
      <last_name>Sharad Wadhwani, MD, MPH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Healthcare of Atlanta</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30329</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hillary Espinoza</last_name>
      <phone>404-785-1203</phone>
      <email>hillary.espinoza@choa.org</email>
    </contact>
    <investigator>
      <last_name>Nitika Gupta, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ann &amp; Robert H. Lurie Children's Hospital of Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mary Riordan</last_name>
      <email>mriordan@luriechildrens.org</email>
    </contact>
    <investigator>
      <last_name>Saeed Mohammad, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Columbia University</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Isaac Effiong</last_name>
      <phone>212-305-3839</phone>
      <email>ie222@cumc.columbia.edu</email>
    </contact>
    <investigator>
      <last_name>Jennifer Vittorio, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cincinnati Children's Hospital Medical Center</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kathleen Campbell, MD</last_name>
      <phone>513-636-4415</phone>
      <email>kathleen.campbell@cchmc.org</email>
    </contact>
    <investigator>
      <last_name>Kathleen Campbell, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UPMC Children's Hospital of Pittsburgh</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15224</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexandra Kepler, MPH</last_name>
      <phone>412-692-6692</phone>
      <email>alexandra.kepler@upmc.edu</email>
    </contact>
    <investigator>
      <last_name>James Squires, MD, MS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Medical Center Dallas</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75235</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jatin Moghe</last_name>
      <email>jatin.moghe@childrens.com</email>
    </contact>
    <investigator>
      <last_name>Dev Desai, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Seattle Children's Hospital</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kara Cooper</last_name>
      <phone>206-987-4636</phone>
      <email>kara.cooper@seattlechildrens.org</email>
    </contact>
    <investigator>
      <last_name>Evelyn Hsu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 9, 2020</study_first_submitted>
  <study_first_submitted_qc>September 10, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 16, 2020</study_first_posted>
  <last_update_submitted>September 1, 2021</last_update_submitted>
  <last_update_submitted_qc>September 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pediatric</keyword>
  <keyword>Health services research</keyword>
  <keyword>Social determinants of health</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

